1. 1) Lobins R and Floyd J : Small cell carcinoma of unknown primary. Semin Oncol 34: 39–42, 2007.
2. 2) Renner G : Small cell carcinoma of the head and neck: a review. Semin Oncol 34: 3–14, 2007.
3. 3) Brennan SM, Gregory DL, Stillie A, et al. : Should extrapulmonary small cell cancer be managed like small cell lung cancer? Cancer 116: 888–895, 2010.
4. 4) Lara PN Jr, Chansky K, Shibata T, et al. : Common arm comparative outcomes analysis of phase 3 trials of cisplatin+irinotecan versus cisplatin+etoposide in extensive stage small cell lung cancer: final patient-level results from Japan Clinical Oncology Group 9511 and Southwest Oncology Group 0124. Cancer 116: 5710–5715, 2010.
5. 5) Kelley MJ, Bogart JA, Hodgson LD, et al. : Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206. J Thorac Oncol 8: 102–108, 2013.